BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer | Cell Death & Differentiation
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Cancers | Free Full-Text | BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect
![PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/423098cc326d4983e1c46704685fa877fa0ac94e/3-Table2-1.png "PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar")
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
![PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/423098cc326d4983e1c46704685fa877fa0ac94e/2-Table1-1.png "PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar")
PDF] Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer? | Semantic Scholar
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin | PLOS ONE
Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC
Bax expression is a candidate prognostic and predictive marker of colorectal cancer - Katkoori - Journal of Gastrointestinal Oncology
BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer | Cell Death & Disease
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
PDF) ANALYSIS OF ANTIAPOPTOTIC PROTEIN BCL2 BY IMMUNOHISTOCHEMISTRY AND ITS CORRELATION WITH THE PROGNOSIS IN PATIENT WITH COLORECTAL CANCER
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability | Oncogene
Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment - ScienceDirect
Is Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?
Bcl-2 as a clinical prognostic marker. | Download Table
Colorectal Cancer Screening Methods and Molecular Markers for Early Detection - Ziwei Wu, You Li, Yibin Zhang, Hui Hu, Tangwei Wu, Shuiyi Liu, Weiqun Chen, Shenggao Xie, Zhongxin Lu, 2020
